Peter Wrighton-Smith
Gründer bei Oxford Immunotec Ltd.
Ursprung des Netzwerks ersten Grades von Peter Wrighton-Smith
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Medical Specialties | 27 | |
Oxford Immunotec Ltd.
 Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.
21
| Subsidiary | Medical Specialties | 21 |
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom.
14
| Holding Company | Packaged Software | 14 |
Quest Diagnostics TB LLC
 Quest Diagnostics TB LLC Medical SpecialtiesHealth Technology Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.
12
| Subsidiary | Medical Specialties | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter Wrighton-Smith
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Chief Investment Officer Private Equity Investor Director/Board Member Private Equity Analyst | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member President Corporate Officer/Principal | |
Ieso Digital Health Ltd.
 Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom. | Commercial Printing/Forms | Chief Executive Officer Chairman Director/Board Member | |
Veryan Medical Ltd.
 Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Chairman Corporate Officer/Principal | |
| TOUCHSTONE INNOVATIONS PLC | Investment Managers | Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Matritech, Inc.
 Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Medical Specialties | Director of Finance/CFO General Counsel | |
| Northeastern University School of Law | College/University | Graduate Degree Graduate Degree | |
Molten Ventures (Private Equity)
 Molten Ventures (Private Equity) Investment ManagersFinance Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Veryan Holdings Ltd.
 Veryan Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Otsuka Holdings Co., Ltd., Veryan Holdings Ltd. is a holding British company that provides research and development services for clinical trials of novel vascular devices. The company is based in Oxford, UK and was founded in 2007. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| University of Wisconsin | College/University | Undergraduate Degree Graduate Degree | |
Inform Diagnostics, Inc.
 Inform Diagnostics, Inc. Hospital/Nursing ManagementHealth Services Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX. | Hospital/Nursing Management | Chief Executive Officer Chief Executive Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Human Resources Officer Compliance Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| Mobility Health, Inc. | Director/Board Member Director/Board Member | ||
| University of California, Berkeley | College/University | Masters Business Admin Doctorate Degree | |
| NEOGENOMICS, INC. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Resolys Bio, Inc.
 Resolys Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Resolys Bio, Inc. operates as a pharmaceutical company. The firm develops OSLO and MCC for the treatment of certain forms of traumatic brain injury and chronic painful tissue disorders. The company is headquartered in Delanson, NY. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| BECTON, DICKINSON AND COMPANY | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| PRECIPIO, INC. | Medical/Nursing Services | Director/Board Member Chairman | |
| London Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
GE Healthcare, Inc.
 GE Healthcare, Inc. Medical SpecialtiesHealth Technology GE Healthcare, Inc. manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. It offers dyes that are used in magnetic-resonance-imaging procedures. The firm also manufactures medical diagnostic equipment including CT image machines. It develops healthcare technological solutions for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing. The company was founded in 1994 and is headquartered in Princeton, NJ. | Medical Specialties | Corporate Officer/Principal Director of Finance/CFO | |
Assurex Health, Inc.
 Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
OBS Medical Ltd.
 OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Electronic Equipment/Instruments | Chairman Director/Board Member | |
Abcodia Ltd.
 Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Seton Hall University | College/University | Undergraduate Degree Graduate Degree | |
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Stanmore Implants Worldwide Ltd.
 Stanmore Implants Worldwide Ltd. Medical SpecialtiesHealth Technology Stanmore Implants Worldwide, Ltd. designs and manufactures bespoke and modular implants for limb sparing and complex joint replacement. It provides massive endoprothesis tumour systems for orthopedic skeletal locations including the femur, tibia, knee, pelvis and humerus. The firm also offers computer assisted orthopedic surgeries. The company was founded on February 19, 1996 and is headquartered in Elstree, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
| GlaxoWellcome /Pharmocology Unit/ | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Analyst | |
| REVVITY, INC. | Medical Specialties | Chief Administrative Officer | |
| MODERNA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Mitek Surgical Products, Inc.
 Mitek Surgical Products, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Mitek Surgical Products, Inc. is a company that specializes in surgical implants. The company is based in Norwood, MA. The company was founded by James E. Nicholson. Mitek Surgical Products was acquired by Johnson & Johnson on April 15, 1995 for $128 million. | Medical Specialties | Director of Finance/CFO | |
| Serono Corp. | Corporate Officer/Principal | ||
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| University College Dublin | College/University | Doctorate Degree | |
| University of Leeds | College/University | Undergraduate Degree | |
SPARK Impact Ltd.
 SPARK Impact Ltd. Investment ManagersFinance SPARK Impact Ltd (SPARK Impact) is a venture capital firm founded in 2010. The firm is headquartered in North East, United Kingdom. | Investment Managers | Private Equity Investor | |
Handsome Ltd.
 Handsome Ltd. Pharmaceuticals: OtherHealth Technology Handsome Ltd. provides medical product for spinal relief. The company was founded by Adrian Collins, John Sutcliffe, Mark Critchley and Russell Lloyd in 2011 and is headquartered in Altrincham, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
Zilico Ltd.
 Zilico Ltd. BiotechnologyHealth Technology Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 24 |
| Vereinigtes Königreich | 23 |
| Deutschland | 3 |
| Frankreich | 2 |
| Israel | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Finance | 6 |
| Health Services | 4 |
Operativ
| Director/Board Member | 248 |
| Corporate Officer/Principal | 109 |
| Independent Dir/Board Member | 42 |
| Chairman | 38 |
| Chief Executive Officer | 32 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Simon Cartmell | 39 |
| Michael Steinmetz | 35 |
| Vijay K. Lathi | 33 |
| Nigel Pitchford | 29 |
| Ronald Andrews | 27 |
| James Tobin | 26 |
| Richard Sandberg | 23 |
| Patrick Balthrop | 21 |
| Herm Rosenman | 21 |
| Robert Tansley | 18 |
| Jonathan Charles Gee | 17 |
| Jeffrey H. Buchalter | 15 |
| Michael T. Stocum | 15 |
| Robert Woodman | 14 |
| Andrew Scott Walton | 14 |
- Börse
- Insiders
- Peter Wrighton-Smith
- Unternehmensverbindungen
